{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:11:34Z","timestamp":1778886694349,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904072"],"award-info":[{"award-number":["81904072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26810","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T14:24:48Z","timestamp":1708698288000},"page":"e26810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6901-5142","authenticated-orcid":false,"given":"YiFei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingluan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e26810_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e26810_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","article-title":"Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors","volume":"72","author":"Kerr","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","article-title":"Spectrum of Epstein-Barr virus-associated diseases","volume":"1","author":"Kutok","year":"2006","journal-title":"Annu. Rev. Pathol."},{"issue":"Pt 1","key":"10.1016\/j.heliyon.2024.e26810_bib4","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26810_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1040-8428(02)00119-1","article-title":"Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"44","author":"Kasahara","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e26810_bib6","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/apa.15973","article-title":"Virus-triggered secondary hemophagocytic lymphohistiocytosis","volume":"110","author":"Imashuku","year":"2021","journal-title":"Acta Paediatr."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e26810_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev. Med. Virol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e26810_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood.2020005041","article-title":"Checkmate for EBV-HLH","volume":"135","author":"El-Mallawany","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e26810_bib9","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3389\/fimmu.2017.01902","article-title":"Epstein-barr virus and hemophagocytic lymphohistiocytosis","volume":"8","author":"Marsh","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26810_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein-Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e26810_bib12","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1002\/jmv.26941","article-title":"Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China","volume":"93","author":"Shi","year":"2021","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e26810_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.26544","article-title":"Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan","volume":"97","author":"Yamamoto","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fped.2019.00014","article-title":"Advances in the study of chronic active Epstein-Barr virus infection: clinical features under the 2016 WHO classification and mechanisms of development","volume":"7","author":"Arai","year":"2019","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26810_bib15","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1038\/emm.2014.88","article-title":"Modeling EBV infection and pathogenesis in new-generation humanized mice","volume":"47","author":"Fujiwara","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"6\u20137","key":"10.1016\/j.heliyon.2024.e26810_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00439-020-02145-3","article-title":"Genetic susceptibility to EBV infection: insights from inborn errors of immunity","volume":"139","author":"Tangye","year":"2020","journal-title":"Hum. Genet."},{"key":"10.1016\/j.heliyon.2024.e26810_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.935205","article-title":"EBV infection and its regulated metabolic reprogramming in nasopharyngeal tumorigenesis","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-023-02648-9","article-title":"Association between atopic dermatitis, autoimmune illnesses, Epstein-Barr virus, and cytomegalovirus","author":"Fuxench","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.heliyon.2024.e26810_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","article-title":"Epstein-Barr virus-associated gastric cancer: a distinct subtype","volume":"4110","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26810_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1040-8428(02)00115-4","article-title":"Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies","volume":"44","author":"Kanegane","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-981-10-5765-6_6","article-title":"EBV infection and glucose metabolism in nasopharyngeal carcinoma","volume":"1018","author":"Zhang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e26810_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1006\/scbi.2001.0412","article-title":"Role of LMP1 in immune control of EBV infection","volume":"11","author":"Pai","year":"2001","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e26810_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0966-842X(00)01742-X","article-title":"The ins and outs of EBV infection","volume":"8","author":"Faulkner","year":"2000","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587078","article-title":"Epstein-barr virus and multiple sclerosis","volume":"11","author":"Houen","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26810_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jbspin.2017.04.011","article-title":"Epstein-Barr virus and rheumatoid arthritis","volume":"85","author":"Balandraud","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.heliyon.2024.e26810_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26810_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","article-title":"EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e26810_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101272","article-title":"MicroRNA-mediated control of Epstein-Barr virus infection and potential diagnostic and therapeutic implications","volume":"56","author":"Skalsky","year":"2022","journal-title":"Curr Opin Virol"},{"issue":"5671","key":"10.1016\/j.heliyon.2024.e26810_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","journal-title":"Science"},{"issue":"7043","key":"10.1016\/j.heliyon.2024.e26810_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26810_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e26810_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2867","article-title":"Genetic variation in microRNA networks: the implications for cancer research","volume":"10","author":"Ryan","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26810_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.heliyon.2024.e26810_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ebiom.2016.06.041","article-title":"Targeting the Ca(2+) sensor STIM1 by exosomal transfer of ebv-miR-BART13-3p is associated with sj\u00f6gren's syndrome","volume":"10","author":"Gallo","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e26810_bib36","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.3389\/fimmu.2019.00695","article-title":"Epstein-barr virus and miRNAs: partners in crime in the pathogenesis of multiple sclerosis?","volume":"10","author":"Hassani","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26810_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12935-018-0637-5","article-title":"Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation","volume":"18","author":"Jing","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e26810_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.canlet.2016.12.003","article-title":"Global profiling of viral and cellular non-coding RNAs in Epstein-Barr virus-induced lymphoblastoid cell lines and released exosome cargos","volume":"388","author":"Gallo","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e26810_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fimmu.2017.00118","article-title":"Circulating microRNAs as potential biomarkers of infectious disease","volume":"8","author":"Correia","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib41","article-title":"Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e26810_bib42","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/humrep\/dez116","article-title":"Plasma miRNAs as biomarkers for endometriosis","volume":"34","author":"Vanhie","year":"2019","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.heliyon.2024.e26810_bib43","first-page":"14","article-title":"Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort","author":"Ali","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26810_bib44","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1080\/21691401.2019.1671432","article-title":"Exosomal miR-320d derived from adipose tissue-derived MSCs inhibits apoptosis in cardiomyocytes with atrial fibrillation (AF)","volume":"47","author":"Liu","year":"2019","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib45","first-page":"sjac234","article-title":"CD30 regulation of IL-13-STAT6 pathway in breast implant associated anaplastic large cell lymphoma","author":"Kadin","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"Suppl","key":"10.1016\/j.heliyon.2024.e26810_bib46","first-page":"C167","article-title":"Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships","volume":"10","author":"Hao","year":"2014","journal-title":"J Cancer Res Ther"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e26810_bib47","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2014.04.002","article-title":"Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"45","author":"Wu","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12935-018-0637-5","article-title":"Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation","volume":"18","author":"Jing","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e26810_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcv.2017.04.002","article-title":"EBV-encoded microRNAs profile evaluation in pediatric liver transplant recipients","volume":"91","author":"Bergallo","year":"2017","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e26810_bib50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s13402-020-00538-0","article-title":"EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway","volume":"43","author":"Dong","year":"2020","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.heliyon.2024.e26810_bib51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.omtn.2020.09.021","article-title":"miR-4721, induced by EBV-miR-BART22, targets GSK3\u03b2 to enhance the tumorigenic capacity of NPC through the WNT\/\u03b2-catenin pathway","volume":"22","author":"Tang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26810_bib52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41419-022-05107-x","article-title":"Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e26810_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198567","article-title":"MiR-BART2-3p targets Unc-51-like kinase 1 and inhibits cell autophagy and migration in Epstein-Barr virus-associated gastric cancer","volume":"305","author":"Shi","year":"2021","journal-title":"Virus Res."},{"key":"10.1016\/j.heliyon.2024.e26810_bib54","article-title":"The role of EBV-encoded miRNA in EBV-associated gastric cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Oncol."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e26810_bib55","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020009499","article-title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","volume":"137","author":"Chaturvedi","year":"2021","journal-title":"Blood"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402402841X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402402841X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:31:38Z","timestamp":1778884298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402402841X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S240584402402841X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26810","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26810"}}